NeuroOne Medical Technologies Corporation (NMTC)

NASDAQ: NMTC · IEX Real-Time Price · USD
1.210
+0.080 (7.08%)
At close: Feb 29, 2024, 4:00 PM
1.200
-0.010 (-0.83%)
After-hours: Feb 29, 2024, 4:33 PM EST
7.08%
Market Cap 29.30M
Revenue (ttm) 2.82M
Net Income (ttm) -13.47M
Shares Out 25.93M
EPS (ttm) -0.68
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 221,668
Open 1.130
Previous Close 1.130
Day's Range 1.130 - 1.280
52-Week Range 0.850 - 2.070
Beta 1.08
Analysts Strong Buy
Price Target 2.20 (+81.82%)
Earnings Date Feb 13, 2024

About NMTC

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with R... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2009
Employees 16
Stock Exchange NASDAQ
Ticker Symbol NMTC
Full Company Profile

Financial Performance

In 2023, NMTC's revenue was $3.41 million, an increase of 60.73% compared to the previous year's $2.12 million. Losses were -$11.86 million, 18.6% more than in 2022.

Financial Statements

Analyst Forecast

According to one analyst, the rating for NMTC stock is "Strong Buy" and the 12-month stock price forecast is $2.2.

Price Target
$2.2
(81.82% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica...

5 days ago - GlobeNewsWire

NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

EDEN PRAIRIE, Minn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgica...

16 days ago - GlobeNewsWire

NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13

EDEN PRAIRIE, Minn., Feb. 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica...

21 days ago - GlobeNewsWire

NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update

EDEN PRAIRIE, Minn., Dec. 14, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica...

2 months ago - GlobeNewsWire

NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14

EDEN PRAIRIE, Minn., Dec. 07, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica...

3 months ago - GlobeNewsWire

NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe

Patent allowance strengthens IP portfolio and positions company in pursuing drug delivery using its neural probes

3 months ago - GlobeNewsWire

NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Volker strengthens existing management team in areas of commercialization, business development, and reimbursement

3 months ago - GlobeNewsWire

NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023

EDEN PRAIRIE, Minn., Oct. 13, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica...

4 months ago - GlobeNewsWire

NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment Conference

EDEN PRAIRIE, Minn., Sept. 06, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgic...

6 months ago - GlobeNewsWire

NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update

EDEN PRAIRIE, Minn., Aug. 14, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica...

7 months ago - GlobeNewsWire

NeuroOne® to Report Third Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on August 14

EDEN PRAIRIE, Minn., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica...

7 months ago - GlobeNewsWire

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

EDEN PRAIRIE, Minn., July 24, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care options...

7 months ago - GlobeNewsWire

NeuroOne® Submits 510(k) Application to FDA for OneRF™ Ablation System

Potential for tran s formative improvement in neurosurgery as f irst known sEEG -guided RF system that records and ablates nervous tissue with the added benefit of temperature control

9 months ago - GlobeNewsWire

NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode in Robotic Neurosurgery

Evo sEEG electrode used with Zimmer Biomet 's ROSA One ® Brain during procedure at Cleveland Clinic

10 months ago - GlobeNewsWire

NeuroOne® Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update

EDEN PRAIRIE, Minn., May 11, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical...

10 months ago - GlobeNewsWire

NeuroOne® to Report Second Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on May 11

EDEN PRAIRIE, Minn., May 11, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical...

10 months ago - GlobeNewsWire

NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode Performed at Mayo Clinic

Evo sEEG electrode s used for brain mapping in epilepsy surgery

10 months ago - GlobeNewsWire

NeuroOne® to Present at the Sidoti Micro-Cap Virtual Conference on May 10

EDEN PRAIRIE, Minn., May 05, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical...

10 months ago - GlobeNewsWire

NeuroOne® Announces U.S. Commercial Launch of Evo® sEEG Electrodes

Evo sEEGs complementary to Zimmer Biomet's robotic neurosurgery platform; strong market opportunity for paired technologies

10 months ago - GlobeNewsWire

NeuroOne® Successfully Completes Initial Animal Implant of Novel Thin Film Paddle Lead for Spinal Cord Stimulation

Company is also developing a percutaneous (through a needle) delivery system for paddle leads EDEN PRAIRIE, Minn. , March 16, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NM...

1 year ago - PRNewsWire

NeuroOne®#¹⁶⁰;to Participate in the 35th Annual Roth Conference

EDEN PRAIRIE, Minn. , March 9, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical c...

1 year ago - PRNewsWire

NeuroOne® Awarded U.S. Patent Covering Novel and Proprietary Thin Film Electrode Platform

New patent adds value to NeuroOne's growing patent portfolio in the U.S. and abroad EDEN PRAIRIE, Minn. , March 7, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("Neuro...

1 year ago - PRNewsWire

NeuroOne® Reports First Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update

EDEN PRAIRIE, Minn. , Feb. 14, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical c...

1 year ago - PRNewsWire

NeuroOne® to Report First Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on February 14

EDEN PRAIRIE, Minn. , Feb. 9, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical ca...

1 year ago - PRNewsWire

NeuroOne® Issues Letter to Shareholders

Company highlights fiscal year 2022 and subsequent achievements, catalysts for fiscal year 2023 EDEN PRAIRIE, Minn. , Jan. 30, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: N...

1 year ago - PRNewsWire